 16item 6selected financial data 16item 7managements discussion and analysis of financial condition and results of operations 17item 7aquantitative and qualitative disclosures about market risk 48item 8financial statements and supplementary data 48item 9changes in and disagreements with accountants on accounting and financial disclosure 48item 9acontrols and procedures 48item 9bother information 48   part iii  item 10directors executive officers and corporate governance 49item 11executive compensation 49item 12security ownership of certain beneficial owners and management and related stockholder matters 50item 13certain relationships and related transactions and director independence 50item 14principal accountant fees and services 50   part iv  item 15exhibits and financial statement schedules 51   signatures 52part iitem 1 businessa general development of the businesscolgatepalmolive company together with its subsidiaries the company or colgate is a leading consumer products company whose products are marketed in over 200 countries and territories throughout the world colgate was founded in 1806 and incorporated under the laws of the state of delaware in 1923for recent business developments and other information refer to the information set forth under the captions executive overview and outlook results of operations restructuring and related implementation charges and liquidity and capital resources in part ii item 7 of this reportb financial information about segmentsworldwide net sales and operating profit by business segment and geographic region during the last three years appear under the caption results of operations in part ii item 7 of this report and in note 15 segment information to the consolidated financial statementsc narrative description of the businessthe company operates in two product segments oral personal and home care and pet nutrition colgate is a global leader in oral care with the leading toothpaste and manual toothbrush brands throughout many parts of the world according to market share data colgates oral care products include colgate total colgate sensitive prorelief colgate max fresh colgate optic white and colgate luminous white toothpastes colgate 360 and colgate slim soft manual toothbrushes and colgate optic white colgate total and colgate plax mouthwash colgates oral care business also includes pharmaceutical products for dentists and other oral health professionalscolgate is a leader in many product categories of the personal care market with global leadership in liquid hand soap which it sells under the palmolive protex and softsoap brands colgates personal care products also include palmolive sanex and softsoap brand shower gels palmolive irish spring and protex bar soaps and speed stick lady speed stick and sanex deodorants and antiperspirants colgate is the market leader in liquid hand soap in the us with its line of softsoap brand products according to market share data colgates personal care business outside the us also includes palmolive and caprice shampoos and conditionerscolgate manufactures and markets a wide array of products for the home care market including palmolive and ajax dishwashing liquids fabuloso and ajax household cleaners and murphys oil soap colgate is a market leader in fabric softeners with leading brands including suavitel in latin america and soupline in europe colgate is a market leader in fabric softeners in the south pacific according to market share datasales of oral personal and home care products accounted for 46 21 and 20 respectively of the companys total worldwide net sales in 2014 geographically oral care is a significant part of the companys business in asia comprising approximately 86 of net sales in that region for 2014 1colgate through its hills pet nutrition segment hills is a world leader in specialty pet nutrition products for dogs and cats with products marketed in over 95 countries worldwide hills markets pet foods primarily under three trademarks hills science diet which is sold by authorized pet supply retailers and veterinarians for everyday nutritional needs hills prescription diet a range of therapeutic products sold by veterinarians and authorized pet supply retailers to help nutritionally manage disease conditions in dogs and cats and hills ideal balance a range of products with natural ingredients sold by authorized pet supply retailers and veterinarians sales of pet nutrition products accounted for 13 of the companys total worldwide net sales in 2014for more information regarding the companys worldwide net sales by product category refer to note 1 nature of operations and note 15 segment information to the consolidated financial statements for additional information regarding market share data see market share information in part ii item 7 of this reportresearch and developmentstrong research and development capabilities and alliances enable colgate to support its many brands with technologically sophisticated products to meet consumers oral personal and home care and pet nutrition needs the companys spending related to research and development activities was 277 million in 2014 267 million in 2013 and 259 million in 2012distribution raw materials competition trademarks and patentsthe companys products are marketed by a direct sales force at individual operating subsidiaries or business units and by distributors or brokers no single customer accounts for 10 or more of the companys salesthe majority of raw and packaging materials are purchased from other companies and are available from several sources no single raw or packaging material represents and no single supplier provides a significant portion of the companys total material requirements for certain materials however new suppliers may have to be qualified under industry governmental and colgate standards which can require additional investment and take some period of time raw and packaging material commodities such as resins pulp essential oils tropical oils tallow poultry corn and soybeans are subject to market price variationsthe companys products are sold in a highly competitive global marketplace which has experienced increased trade concentration and the growing presence of largeformat retailers and discounters products similar to those produced and sold by the company are available from multinational and local competitors in the us and overseas certain of the companys competitors are larger and have greater resources than the company in addition private label brands sold by retail trade chains are a source of competition for certain of the companys product lines product quality innovation brand recognition marketing capability and acceptance of new products largely determine success in the companys operating segmentstrademarks are considered to be of material importance to the companys business the company follows a practice of seeking trademark protection in the us and throughout the world where the companys products are sold principal global and regional trademarks include colgate palmolive speed stick lady speed stick softsoap irish spring protex sorriso kolynos elmex toms of maine sanex ajax axion fabuloso soupline and suavitel as well as hills science diet hills prescription diet and hills ideal balance the companys rights in these trademarks endure for as long as they are used andor registered although the company actively develops and maintains a portfolio of patents no single patent is considered significant to the business as a wholeenvironmental mattersthe company has programs that are designed to ensure that its operations and facilities meet or exceed standards established by applicable environmental rules and regulations capital expenditures for environmental control facilities totaled 41 million for 2014 for future years expenditures are currently expected to be of a similar magnitude for additional information regarding environmental matters refer to note 13 commitments and contingencies to the consolidated financial statements  2employeesas of december 31 2014 the company employed approximately 37700 employeesexecutive officers of the registrantthe following is a list of executive officers as of february 19 2015name age date first elected officer present titleian cook 62 1996 chairman of the board      president and chief executive officerfabian t garcia 55 2003 chief operating officer      global innovation and growth europesouth pacific      and hills pet nutritionfranck j moison 61 2002 chief operating officer      emerging markets and business developmentdennis j hickey 66 1998 chief financial officerandrew d hendry 67 1991 vice chairmanjennifer m daniels 51 2014 chief legal officer and secretaryvictoria l dolan 55 2011 vice president and corporate controllerjohn j huston 60 2002 senior vice president      office of the chairmandelia h thompson 65 2002 senior vice president      investor relationsdaniel b marsili 54 2005 senior vice president      global human resourcesp justin skala 55 2008 president      colgate  north america and global sustainabilitynoel r wallace 50 2009 president      colgate  latin americapatricia verduin 55 2011 chief technology officernigel b burton 56 2012 chief marketing officereach of the executive officers listed above has served the registrant or its subsidiaries in various executive capacities for the past five years with the exception of jennifer m daniels who joined the company in 2014 as chief legal officer and secretary ms daniels joined the company from ncr corporation where she was senior vice president general counsel and secretary prior to joining ncr corporation in 2010 ms daniels was vice president general counsel and secretary of barnes amp noble inc which she joined in 2007under the companys bylaws the officers of the corporation hold office until their respective successors are chosen and qualified or until they have resigned retired or been removed by the affirmative vote of a majority of the board of directors of the company the board there are no family relationships between any of the executive officers and there is no arrangement or understanding between any executive officer and any other person pursuant to which the executive officer was electedd financial information about geographic areasfor financial data by geographic region refer to the information set forth under the caption results of operations in part ii item 7 of this report and in note 15 segment information to the consolidated financial statements for a discussion of risks associated with our international operations see item 1a risk factors 3e available informationthe companys web site address is wwwcolgatepalmolivecom the information contained on the companys web site is not included as a part of or incorporated by reference into this annual report on form 10k the company makes available free of charge on its web site its annual reports on form 10k its quarterly reports on form 10q its interactive data files posted pursuant to rule 405 of regulation st its current reports on form 8k and amendments to such reports filed or furnished pursuant to section 13a or 15d of the securities exchange act of 1934 the exchange act as soon as reasonably practicable after the company has electronically filed such material with or furnished it to the united states securities and exchange commission the sec also available on the companys web site are the companys code of conduct and corporate governance guidelines the charters of the committees of the board reports under section 16 of the exchange act of transactions in company stock by directors and officers and its proxy statementsitem 1a risk factorsset forth below is a summary of the material risks to an investment in our securities these risks are not the only ones we face additional risks not presently known to us or that we currently deem immaterial may also have an adverse effect on us if any of the below risks actually occur our business results of operations cash flows or financial condition could be materially and adversely impacted which might cause the value of our securities to declinewe face risks associated with significant international operations including exposure to foreign currency fluctuationswe operate on a global basis with approximately 80 of our net sales originating in markets outside the us while geographic diversity helps to reduce our exposure to risks in any one country or part of the world it also means that we are subject to the full range of risks associated with significant international operations including but not limited tochanges in exchange rates for foreign currencies which may reduce the us dollar value of revenues profits and cash flows we receive from nonus markets or increase our supply costs as measured in us dollars in those marketsexchange controls and other limits on our ability to import raw materials or finished product or to repatriate earnings from overseaspolitical or economic instability social or labor unrest or changing macroeconomic conditions in our markets including as a result of volatile commodity prices including the price of oillack of wellestablished or reliable legal systems in certain countries where we operateforeign ownership restrictions and the potential for nationalization or expropriation of property or other resources andother foreign or domestic legal and regulatory requirements including those resulting in potentially adverse tax consequences or the imposition of onerous trade restrictions price controls labor laws profit controls or other government controlsthese risks could have a significant impact on our ability to sell our products on a competitive basis in international markets and may adversely affect our business results of operations cash flows and financial conditionin an effort to minimize the impact on earnings of foreign currency rate movements we engage in a combination of selling price increases where permitted sourcing strategies costcontainment measures and selective hedging of foreign currency transactions however these measures may not succeed in offsetting any negative impact of foreign currency rate movements on our business and results of operations 4for example the companys ability to manage its venezuelan operations has been and will continue to be negatively impacted by difficult conditions in venezuela including the significant devaluations of the venezuelan bolivar that occurred in 2010 and in february 2013 and the effective devaluations that occurred in 2014 as a result of the introduction of a multitier foreign exchange system in 2014 since april 2012 when price controls affecting most of our venezuelan subsidiarys cp venezuela product portfolio became effective we have not been able to implement price increases without government approval which has limited our ability to offset the effects of continuing high inflation and the impact of currency devaluations in addition labor laws limit our ability to manage overhead costs and at times production at cp venezuela has been negatively impacted by local labor issues going forward additional government actions including in the form of further currency devaluations or effective devaluations or continued or worsening import authorization controls foreign exchange price or profit controls or expropriation or other form of government takeover could have further adverse impacts on our business results of operations cash flows and financial condition as could economic instability resulting from the decline in the price of oil for additional information regarding these and other risks associated with our operations in venezuela refer to part ii item 7 managements discussion and analysis of financial condition and results of operations  executive overview and outlook and note 14 venezuela to the consolidated financial statementssignificant competition in our industry could adversely affect our businesswe face vigorous competition worldwide including from local competitors and other large multinational companies some of which have greater resources than we do we face this competition in several aspects of our business including but not limited to the pricing of products promotional activities new product introductions and expansion into new geographies such competition also extends to administrative and legal challenges of product claims and advertising our ability to compete also depends on the strength of our brands and on our ability to defend our patent trademark and trade dress rights against legal challenges brought by competitorswe may be unable to anticipate the timing and scale of such initiatives or challenges by competitors or to successfully counteract them which could harm our business in addition the cost of responding to such initiatives and challenges including management time outofpocket expenses and price reductions may affect our performance in the relevant period a failure to compete effectively could adversely affect our business results of operations cash flows and financial conditionour business is subject to legal and regulatory risks in the us and abroadour business is subject to extensive legal and regulatory requirements in the us and abroad such legal and regulatory requirements apply to most aspects of our products including their development ingredients manufacture packaging labeling storage transportation distribution export import advertising and sale us federal authorities including the us food and drug administration the fda the federal trade commission the consumer product safety commission and the environmental protection agency regulate different aspects of our business along with parallel authorities at the state and local levels and comparable authorities overseas also our selling practices are regulated by competition law authorities in the us and abroadnew or more stringent legal or regulatory requirements or more restrictive interpretations of existing requirements could adversely impact our business results of operations cash flows and financial condition for example from time to time various regulatory authorities and consumer groups in europe the us and other countries request or conduct reviews of the use of various ingredients in consumer products triclosan an ingredient used by us primarily in colgate total toothpaste and certain other oral care products is an example of an ingredient that has undergone reviews by various regulatory authorities worldwide triclosan is currently being evaluated under the european unions regulation for the registration evaluation authorization and restriction of chemicals reach which requires the registration of all covered chemicals used in the european union by 2018 in the us the fda is evaluating the use of benzalkoniam chloride an ingredient used in certain of our hand soap products and triclosan in hand soaps and hand sanitizers in 2014 a law banning the sale of certain products containing triclosan was passed in minnesota but the law does not cover colgate total toothpaste similar legislation has been proposed in iowa new york and michigan while legislation seeking to ban the sale of all consumer products containing triclosan has been proposed in chicago illinois environment canada the federal environmental authority in canada is also conducting a review to assess human and environmental risks of triclosan and is expected to issue its final assessment in march 2015 depending on the findings in the final assessment it is possible that environment canada will issue voluntary or mandatory risk management measures for triclosan a decision by a regulatory or governmental authority that triclosan or any other of our ingredients should not be used in certain consumer products or should otherwise be newly regulated could adversely impact our business as could negative reactions by our consumers trade customers or nongovernmental organizations to our use of such ingredients additionally an inability to develop new or reformulated products containing alternative ingredients or to obtain regulatory approval of such products on a timely basis could likewise adversely affect our business  5because of our extensive international operations we could be adversely affected by violations of the us foreign corrupt practices act the fcpa and similar worldwide antibribery laws the fcpa and similar worldwide antibribery laws generally prohibit companies and their intermediaries from making improper payments to government officials or other third parties for the purpose of obtaining or retaining business while our policies mandate compliance with these antibribery laws we cannot provide assurance that our internal control policies and procedures will always protect us from reckless or criminal acts committed by our employees jointventure partners or agents violations of these laws or allegations of such violations could disrupt our business and adversely affect our reputation and our business results of operations cash flows and financial conditionwhile it is our policy and practice to comply with all legal and regulatory requirements applicable to our business a finding that we are in violation of or out of compliance with applicable laws or regulations could subject us to civil remedies including fines damages injunctions or product recalls or criminal sanctions any of which could adversely affect our business results of operations cash flows and financial condition even if a claim is unsuccessful is without merit or is not fully pursued the negative publicity surrounding such assertions regarding our products processes or business practices could adversely affect our reputation and brand image for information regarding our legal and regulatory matters see item 3 legal proceedings and note 13 commitments and contingencies to the consolidated financial statementsuncertain global economic conditions and disruptions in the credit markets may adversely affect our businessuncertain global economic conditions could adversely affect our business recent global economic trends pose challenges to our business and could result in declining revenues profitability and cash flows although we continue to devote significant resources to support our brands during periods of economic uncertainty consumers may switch to economy brands which could reduce sales volumes of our products or result in a shift in our product mix from higher margin to lower margin product offerings additionally retailers may increase pressure on our selling prices or increase promotional activity for lowerpriced or value offerings as they seek to maintain sales volumes and marginswhile we currently generate significant cash flows from ongoing operations and have access to global credit markets through our various financing activities a disruption in the credit markets could limit the availability of credit recent and proposed changes in the bank regulatory environment could reduce the ability of financial institutions to extend credit or increase the cost we are charged to receive credit reduced access to credit or increased costs could adversely affect our liquidity and capital resources or significantly increase our cost of capital in addition if any financial institutions that hold our cash or other investments or that are parties to our revolving credit facilities supporting our commercial paper program or other financing arrangements such as interest rate or foreign exchange hedging instruments were to declare bankruptcy or become insolvent they may be unable to perform under their agreements with us this could leave us with reduced borrowing capacity or unhedged against certain interest rate or foreign currency exposures in addition tighter credit markets may lead to business disruptions for certain of our suppliers contract manufacturers or trade customers which could in turn adversely impact our business results of operations cash flows and financial conditionincreasing dependence on key retailers in developed markets changes in the policies of our retail trade customers and the emergence of new sales channels may adversely affect our businessour products are sold in a highly competitive global marketplace which has experienced increased trade concentration and the growing presence of largeformat retailers and discounters with the growing trend toward retail trade consolidation we are increasingly dependent on key retailers and some of these retailers including largeformat retailers may have greater bargaining strength than we do they may use this leverage to demand higher trade discounts allowances or slotting fees which could lead to reduced sales or profitabilitywe may also be negatively affected by changes in the policies of our retail trade customers such as inventory destocking limitations on access to shelf space delisting of our products environmental or sustainability initiatives and other conditions for example a determination by a key retailer that any of our ingredients should not be used in certain consumer products could adversely impact our business results of operations cash flows and financial condition in addition private label products sold by retail trade chains which are typically sold at lower prices than branded products are a source of competition for certain of our product lines including liquid hand soaps and shower gels the emergence of new sales channels such as sales via ecommerce may affect consumer preferences and market dynamics and could also adversely impact our business results of operations cash flows and financial condition 6the growth of our business depends on the successful identification development and launch of innovative new productsour growth depends on the continued success of existing products as well as the successful identification development and launch of innovative new products and line extensions the identification development and introduction of innovative new products and line extensions involve considerable costs and any new product or line extension may not generate sufficient customer and consumer interest and sales to become a profitable product or to cover the costs of its development and promotion our ability to achieve a successful launch of a new product or line extension could be adversely affected by preemptive actions taken by competitors in response to the launch such as increased promotional activities and advertising in addition our ability to create new products and line extensions and to sustain existing products is affected by whether we can successfullyidentify develop and fund technological innovationsobtain and maintain necessary patent and trademark protection and avoid infringing intellectual property rights of othersobtain approvals and registrations of regulated products including from the fda and other regulatory bodies in the us and abroad andanticipate and respond to consumer needs and preferencesthe failure to develop and launch successful new products could hinder the growth of our business and any delay in the development or launch of a new product could result in us not being the first to market which could compromise our competitive position and adversely affect our business results of operations cash flows and financial conditionif in the course of identifying or developing new products we are found to have infringed the trademark trade secret copyright patent or other intellectual property rights of others directly or indirectly through the use of thirdparty ideas or technologies such a finding could adversely affect our ability to develop innovative new products and adversely affect our business results of operations cash flows and financial condition even if we are not found to infringe on a third partys intellectual property rights claims of infringement could adversely affect us including by increasing costs and by delaying the launch of new products we may not realize the benefits that we expect from our 2012 restructuring programin the fourth quarter of 2012 we commenced a fouryear global growth and efficiency program for sustained growth which was expanded in the fourth quarter of 2014 to take advantage of additional savings opportunities as expanded the 2012 restructuring program the 2012 restructuring programs initiatives are expected to help us ensure continued and solid worldwide growth in unit volume organic sales and earnings per share and enhance our global leadership positions in our core businesses the successful implementation of the remainder of the 2012 restructuring program presents significant organizational challenges and in many cases requires successful negotiations with third parties including labor organizations suppliers and other business partners as a result we may not be able to continue to realize the anticipated benefits from the 2012 restructuring program events and circumstances such as financial or strategic difficulties delays and unexpected costs may occur that could result in our not realizing all of the anticipated benefits or our not realizing the anticipated benefits on our expected timetable if we are unable to realize the anticipated savings of the 2012 restructuring program our ability to fund other initiatives and enhance profitability may be adversely affected any failure to implement the 2012 restructuring program in accordance with our expectations could adversely affect our business results of operations cash flows and financial condition for additional information regarding the 2012 restructuring program refer to part ii item 7 managements discussion and analysis of financial condition and results of operations  executive overview and outlook and  restructuring and related implementation charges 7volatility in material and other costs and our increasing dependence on key suppliers could adversely impact our profitabilityraw and packaging material commodities such as resins pulp essential oils tropical oils tallow poultry corn and soybeans are subject to wide price variations increases in the costs and availability of these commodities and the costs of energy transportation and other necessary services may adversely affect our profit margins if we are unable to pass along any higher costs in the form of price increases or otherwise achieve cost efficiencies such as in manufacturing and distribution in addition our move to global suppliers for materials and other services in order to achieve cost reductions and simplify our business has resulted in an increasing dependence on key suppliers for certain key materials including the triclosan used in colgate total toothpaste we use singlesource suppliers in addition for certain materials new suppliers may have to be qualified under industry governmental and colgate standards which can require additional investment and take a significant period of time while we believe that the supplies of raw materials needed to manufacture our products are adequate global economic conditions supplier capacity constraints climatic events such as droughts or hurricanes and other factors could affect the availability of or prices for those raw materials and an interruption in their supply could adversely affect our business results of operations cash flows and financial conditiondamage to our reputation could have an adverse effect on our businessmaintaining our strong reputation with consumers and our trade partners globally is critical to selling our branded products accordingly we devote significant time and resources to programs designed to protect and preserve our reputation such as our ethics and compliance sustainability brand protection and product safety regulatory and quality initiatives in addition third parties sell counterfeit versions of our products which are inferior or may pose safety risks as a result consumers of our brands could confuse our products with these counterfeit products which could cause them to refrain from purchasing our brands in the future and in turn could impair our brand equity and adversely affect our business results of operations cash flows and financial conditionsimilarly adverse publicity about us our brands or our ingredients regarding health concerns legal or regulatory proceedings environmental impacts including packaging energy and water use and waste management or other sustainability issues whether or not deserved could jeopardize our reputation in addition negative posts or comments about us on any social media web site could harm our reputation damage to our reputation or loss of consumer confidence in our products for these or any other reasons could adversely affect our business results of operations cash flows and financial condition as well as require resources to rebuild our reputationour business is subject to product liability false advertising and consumer fraud claimsfrom time to time we may be subject to product liability claims alleging among other things that our products cause damage to property or persons provide inadequate instructions or warnings regarding their use or contain design or manufacturing defects or contaminants in addition from time to time we may be subject to claims from competitors and consumers including consumer class actions alleging that our product claims are deceptive or that our ingredient or content labeling is defective regardless of their merit these claims can require significant time and expense to investigate and defend for example as described in item 3 legal proceedings we have been named in product liability actions alleging that certain talc products we sold prior to 1996 were contaminated with asbestos causing harm to consumers in addition if one of our products or a raw material contained in our products is perceived or found to be defective or unsafe we may need to recall some of our products whether or not a product liability false advertising or consumer fraud claim is successful or a recall is required such assertions could have an adverse effect on our business results of operations cash flows and financial condition and the negative publicity surrounding them could harm our reputation and brand image 8there is no guarantee that our ongoing efforts to reduce costs will be successfulwe develop investments needed to support growth through our continuous companywide initiatives to lower costs and increase effective asset utilization which we refer to as our fundingthegrowth initiatives these initiatives are designed to reduce costs associated with direct materials indirect expenses and distribution and logistics the achievement of our fundingthegrowth targets depends on our ability to successfully identify and realize additional savings opportunities events and circumstances such as financial or strategic difficulties delays and unexpected costs may occur that could result in our not realizing all of the anticipated benefits or our not realizing the anticipated benefits on our expected timetable if we are unable to realize the anticipated savings of our fundingthegrowth initiatives our ability to fund other initiatives and enhance profitability may be adversely affected any failure to implement our fundingthegrowth initiatives in accordance with our expectations could adversely affect our business results of operations cash flows and financial condition for additional information regarding our fundingthegrowth initiatives refer to part ii item 7 managements discussion and analysis of financial condition and results of operations  executive overview and outlookour business is subject to the risks inherent in global manufacturing and sourcing activitieswe are engaged in manufacturing and sourcing of products and materials on a global scale we are subject to the risks inherent in such activities including but not limited toindustrial accidents or other occupational health and safety issuesenvironmental events strikes and other labor disputesdisruptions in logistics loss or impairment of key manufacturing sites raw material and product quality or safety issues the impact on our suppliers of tighter credit or capital markets and natural disasters including climatic events and earthquakes acts of war or terrorism and other external factors over which we have no controlwhile we have business continuity and contingency plans in place for key manufacturing sites and the supply of raw materials significant disruption of manufacturing for any of the above reasons could interrupt product supply and if not remedied have an adverse impact on our business results of operations cash flows and financial conditiona breach of information security a cybersecurity incident or a failure of a key information technology system could adversely impact our business or reputationwe rely extensively on information technology systems including some which are managed hosted provided andor used by third parties and their vendors in order to conduct our business our uses of these systems include but are not limited tocommunicating within the company and with other partiesordering and managing materials from suppliersconverting materials to finished productsreceiving and processing orders from and shipping products to our customersmarketing products to consumers  9collecting and storing customer consumer employee investor and other stakeholder information and personal dataprocessing transactions including but not limited to employee payroll and employee benefitshosting processing and sharing confidential and proprietary research business plans and financial informationcomplying with legal regulatory or tax requirementsproviding data security and handling other processes involved in managing our businessalthough we have network security measures in place our information technology systems have been and will likely continue to be subject to computer viruses or other malicious codes unauthorized access attempts phishing and other cyberattacks to date we have seen no material impact on our business or operations from these attacks however we cannot guarantee that our security efforts will prevent breaches or breakdowns of our or our thirdparty service providers databases or systems if we suffer a loss or disclosure of confidential business or stakeholder information as a result of a breach of our information technology systems including those of thirdparty service providers with whom we have contracted we may suffer reputational competitive andor business harm incur significant costs and be subject to government investigations civil litigation fines andor damages which may adversely impact our business results of operations cash flows and financial condition furthermore while we have disaster recovery and business continuity plans in place if the systems are damaged or cease to function properly for any reason including the poor performance failure or cyberattack of thirdparty service providers catastrophic events power outages cybersecurity breaches network outages failed upgrades or other similar events and if the disaster recovery and business continuity plans do not effectively resolve such issues on a timely basis we may suffer interruptions in our ability to manage or conduct business as well as reputational harm and litigation which may adversely impact our business results of operations cash flows and financial condition our success depends upon our ability to attract and retain key employees and the succession of senior managementour success largely depends on the performance of our management team and other key employees if we are unable to attract and retain talented highly qualified senior management and other key people our business results of operations cash flows and financial condition could be adversely affected in addition if we are unable to effectively provide for the succession of senior management including our chief executive officer our business results of operations cash flows and financial condition may be adversely affected while we follow a disciplined ongoing succession planning process and have succession plans in place for senior management and other key executives these do not guarantee that the services of qualified senior executives will continue to be available to us at particular moments in timewe may acquire or divest brands or businesses which could adversely impact our resultswe may pursue acquisitions of brands or businesses from third parties acquisitions involve numerous risks including difficulties in the integration of the operations technologies services and products of the acquired brands or businesses estimation of and assumption of liabilities and contingencies personnel turnover and the diversion of managements attention from other business priorities which may adversely impact our business results of operations cash flows and financial condition in addition we may be unable to achieve anticipated benefits or cost savings from acquisitions in the timeframe we anticipate or at allmoreover acquisitions could result in substantial additional debt exposure to contingent liabilities such as litigation or earnout obligations the potential impairment of goodwill or other intangible assets or transaction costs all of which may adversely impact our business results of operations cash flows and financial conditionwe also may periodically divest brands or businesses these divestitures may adversely impact our results of operations if we are unable to offset the dilutive impacts from the loss of revenue associated with the divested brands or businesses or otherwise achieve the anticipated benefits or cost savings from the divestitures in addition businesses under consideration for or otherwise subject to divestiture may be adversely impacted prior to the divestiture which could negatively impact our results of operationsitem 1b unresolved staff commentsnone 10item 2 properties the company owns or leases approximately 360 properties which include manufacturing distribution research and office facilities worldwide our corporate headquarters is located in leased property at 300 park avenue new york new yorkin the us the company operates approximately 70 properties of which 15 are owned major us manufacturing and warehousing facilities used by the oral personal and home care product segment of our business are located in morristown new jersey morristown tennessee and cambridge ohio the pet nutrition segment has major manufacturing and warehousing facilities in bowling green kentucky topeka kansas emporia kansas and richmond indiana the primary research center for oral personal and home care products is located in piscataway new jersey and the primary research center for pet nutrition products is located in topeka kansas our global data center is also located in piscataway new jerseyoverseas the company operates approximately 290 properties of which 79 are owned in over 80 countries major overseas manufacturing and warehousing facilities used by the oral personal and home care product segment of our business are located in australia brazil china colombia france greece india italy mexico poland south africa thailand turkey venezuela and vietnam the pet nutrition segment has major manufacturing and warehousing facilities in the czech republic and the netherlandsthe company has shared business service centers in mexico poland and india which are located in leased propertiesall of the facilities we operate are well maintained and adequate for the purpose for which they are intended 11item 3 legal proceedingsas a global company serving consumers in more than 200 countries and territories the company is routinely subject to a wide variety of legal proceedings these include disputes relating to intellectual property contracts product liability marketing advertising foreign exchange controls antitrust and trade regulation as well as labor and employment environmental and tax matters and consumer class actions management proactively reviews and monitors the companys exposure to and the impact of environmental matters the company is party to various environmental matters and as such may be responsible for all or a portion of the cleanup restoration and postclosure monitoring of several sitesthe company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss or range of loss can be reasonably estimated any such accruals are adjusted thereafter as appropriate to reflect changes in circumstancesthe company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities if any when it has determined that a loss is reasonably possible and it is able to determine such estimates for those matters disclosed below the company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is 0 to approximately 200 million based on current exchange rates the estimates included in this amount are based on the companys analysis of currently available information and as new information is obtained these estimates may change due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the company from the matters in question thus the companys exposure and ultimate losses may be higher or lower and possibly significantly so than the amounts accrued or the range disclosed abovebased on current knowledge management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the companys consolidated financial position or its ongoing results of operations or cash flows however in light of the inherent uncertainties noted above an adverse outcome in one or more of these matters could be material to the companys results of operations or cash flows for any particular quarter or year 12brazilian mattersthere are certain tax and civil proceedings outstanding as described below related to the companys 1995 acquisition of the kolynos oral care business from wyeth the sellerthe brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the companys brazilian subsidiary for certain years in connection with the financing of the kolynos acquisition the tax assessments with interest at the current exchange rate are approximately 107 million the company has been disputing the disallowances by appealing the assessments within the internal revenue authoritys appellate process since october 2001 numerous appeals are currently pending at the administrative level in the event the company is ultimately unsuccessful further appeals are available within the brazilian federal courts the company intends to challenge these assessments vigorously although there can be no assurances management believes based on the opinion of its brazilian legal counsel and other advisors that the disallowances are without merit and that the company should ultimately prevail on appeal if necessary in the brazilian federal courts in july 2002 the brazilian federal public attorney filed a civil action against the federal government of brazil laboratorios wyethwhitehall ltda the brazilian subsidiary of the seller and the company as represented by its brazilian subsidiary in the 6th lower federal court in the city of s√£o paulo seeking to annul an april 2000 decision by the brazilian board of tax appeals that found in favor of the sellers brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of kolynos the action seeks to make the companys brazilian subsidiary jointly and severally liable for any tax due from the sellers brazilian subsidiary the case has been pending since 2002 and the lower federal court has not issued a decision although there can be no assurances management believes based on the opinion of its brazilian legal counsel that the company should ultimately prevail in this action the company intends to challenge this action vigorously in december 2005 the brazilian internal revenue authority issued to the companys brazilian subsidiary a tax assessment with interest and penalties of approximately 66 million at the current exchange rate based on a claim that certain purchases of us treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions the company has been disputing the assessment within the internal revenue authoritys administrative appeals process in november 2014 the superior chamber of administrative tax appeals denied the companys most recent appeal further appeals are available both at the administrative level and within the brazilian federal courts although there can be no assurances management believes based on the opinion of its brazilian legal counsel that the tax assessment is without merit and that the company should ultimately prevail on appeal if not at the administrative level in the brazilian federal courts the company intends to challenge this assessment vigorously 13competition matterseuropean competition matterscertain of the companys subsidiaries in europe are subject to investigations and in some cases fines by governmental authorities in a number of european countries related to potential competition law violations the company understands that substantially all of these matters also involve other consumer goods companies andor retail customers the status of the various pending matters is discussed belowfines have been imposed on the company in the following matters although as noted below the company has appealed each of these finesin december 2009 the swiss competition law authority imposed a fine of 6 million on the companys gaba subsidiary for alleged violations of restrictions on parallel imports into switzerland which the company appealed in january 2014 this appeal was denied the company is appealing before the swiss supreme courtin january 2010 the companys spanish subsidiary was fined 3 million by the spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing which the company contested the fine was annulled by the court of appeal in july 2013 the spanish competition law authority is appealing this judgment before the spanish supreme courtin december 2010 the italian competition law authority found that 16 consumer goods companies including the companys italian subsidiary exchanged competitively sensitive information in the cosmetics sector for which the companys italian subsidiary was fined 3 million the company is appealing the fine in the italian courtsin march 2012 the french competition law authority found that three pet food producers including the companys hills french subsidiary had violated competition law for which it imposed a fine of 7 million on the companys hills french subsidiary for alleged restrictions on exports from france which the company contested in october 2013 the companys appeal was denied the company is appealing before the french supreme courtin december 2014 the french competition law authority found that 13 consumer goods companies including the companys french subsidiary exchanged competitively sensitive information related to the french home care and personal care sectors for which the companys french subsidiary was fined 57 million in addition as a result of the companys acquisition of the sanex personal care business in 2011 from unilever nv and unilever plc together with unilever nv unilever pursuant to a business and share sale and purchase agreement the sanex purchase agreement the french competition law authority found that the companys french subsidiary along with another consumer goods company are jointly and severally liable for fines of 25 million assessed against sara lees french subsidiary the company is seeking indemnification for the 25 million fine from unilever under the sanex purchase agreement the company is appealing both fines in the french courtscurrently formal claims of violations or statements of objections are pending against the company as followsin october 2012 the belgian competition law authority alleged that 11 branded goods companies including the companys belgian subsidiary assisted retailers to coordinate their retail prices on the belgian market the defendants have initiated preliminary talks with the authority regarding a possible settlementin july 2014 the greek competition law authority issued a statement of objections alleging the company and its greek subsidiary restricted parallel imports into greece the company has responded to this statement of objections 14australian competition matterin december 2013 the australian competition law authority instituted civil proceedings in the sydney registry of the federal court of australia alleging that three consumer goods companies including the companys australian subsidiary a retailer and a former employee of the companys australian subsidiary violated the australian competition law by coordinating the launching and pricing of ultraconcentrated laundry detergents the company is defending these proceedings since the amount of any potential losses from these proceedings currently cannot be estimated the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these proceedingsthe companys policy is to comply with antitrust and competition laws and if a violation of any such laws is found to take appropriate remedial action and to cooperate fully with any related governmental inquiry competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found while the company cannot predict the final financial impact of these competition law issues as these matters may change the company evaluates developments in these matters quarterly and accrues liabilities as and when appropriatetalcum powder mattersthe company is a defendant in a number of civil actions alleging that certain talc products it sold prior to 1996 were contaminated with asbestos since 2008 the company has challenged and intends to continue to challenge these cases vigorously and although there can be no assurances it believes based on the advice of its legal counsel that they are without merit and the company should ultimately prevail currently there are 13 single plaintiff cases pending against the company in state courts in california delaware illinois maryland new jersey and new york and one case pending in federal court in north carolina 19 similar cases previously filed against the company have been dismissed and final judgment entered in favor of the company to date there have been no findings of liability against the company in any of these cases since the amount of any potential losses from these cases currently cannot be estimated the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these casessome of these cases are currently expected to go to trial in 2015 although the company may succeed in dismissing or otherwise resolving some or all of them prior to trial as stated above while the company believes based on the advice of its legal counsel that it should ultimately prevail there can be no assurances of the outcome at trial erisa mattersin july 2014 the colgatepalmolive company employees retirement income plan the plan settled a putative class action alleging improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements under the plan under the settlement agreement the plan agreed to pay approximately 40 million after application of certain offsets to resolve the litigation item 4 mine safety disclosuresnot applicable 15part iiitem 5market for registrants common equity related stockholder matters and issuer purchases of equity securitiesfor information regarding the market for the companys common stock including quarterly market prices and dividends and stock price performance graphs refer to market and dividend information included in part iv item 15 of this report for information regarding the number of common shareholders of record refer to historical financial summary included in part iv item 15 of this report for information regarding the securities authorized for issuance under our equity compensation plans refer to security ownership of certain beneficial owners and management and related stockholder matters included in part iii item 12 of this reportissuer purchases of equity securitiesthe share repurchase program approved by the board on september 8 2011 the 2011 program authorized the repurchase of up to 50 million shares of the companys common stock the board authorized that the number of shares remaining under the 2011 program as of may 15 2013 be increased by 100 as a result of the twoforone stock split of the companys common stock in 2013 the board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the companys compensation and benefit programs the shares will be repurchased from time to time in open market or privately negotiated transactions at the companys discretion subject to market conditions customary blackout periods and other factorsthe following table shows the stock repurchase activity for each of the three months in the quarter ended december 31 2014month total number of shares purchased1 average price paid per share total number of shares purchased as part of publicly announced plans or programs2 maximum number of shares that may yet be purchased under the plans or programs3october 1 through 31 2014 864507 6556 791500 9589086november 1 through 30 2014 1715867 6819 1661705 7927381december 1 through 31 2014 3722203 6950 3660593 4266788total 6302577 6860 6113798  1 includes share repurchases under the 2011 program and those associated with certain employee elections under the companys compensation and benefit programs2 the difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 188779 shares all of which relate to shares deemed surrendered to the company to satisfy certain employee elections under the companys compensation and benefit programs3 includes maximum number of shares that were available to be purchased under the publicly announced plans or programs that were in effect on december 31 2014on february 19 2015 the board authorized the repurchase of shares of the companys common stock having an aggregate purchase price of up to 5 billion under a new share repurchase program the 2015 program which replaced the 2011 program the company will commence repurchase of shares of the companys common stock under the 2015 program after february 19 2015